Insider · CIK 0001283303

Reed Elizabeth E

CIK 0001283303 Name as filed on the most recent filing

Filed as Reed Elizabeth E (45)

77 transaction lines · from 45 filings · filed 2006-01-11 to 2026-05-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

77 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-05-06 S, Open-market sale Travere Therapeutics, Inc.TVTX 91,240, disposed Open Form 4 filing 0001283303-26-000009
2026-05-05 S, Open-market sale Travere Therapeutics, Inc.TVTX 101,417, disposed Open Form 4 filing 0001283303-26-000009
2026-05-04 S, Open-market sale Travere Therapeutics, Inc.TVTX 900,000, disposed Open Form 4 filing 0001283303-26-000009
2026-04-15 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 283,810, disposed Open Form 4 filing 0001283303-26-000008
2026-04-14 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 1,842,641, disposed Open Form 4 filing 0001283303-26-000008
2026-04-01 S, Open-market sale Travere Therapeutics, Inc.TVTX 300,000, disposed Open Form 4 filing 0001283303-26-000007
2026-03-16 S, Open-market sale Travere Therapeutics, Inc.TVTX 280,861, disposed Open Form 4 filing 0001283303-26-000006
2026-02-17 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 278,315, disposed Open Form 4 filing 0001283303-26-000005
2026-02-04 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 96,359, disposed Open Form 4 filing 0001283303-26-000003
2026-02-03 S, Open-market sale Travere Therapeutics, Inc.TVTX 230,461, disposed Open Form 4 filing 0001283303-26-000002
2026-01-20 S, Open-market sale Travere Therapeutics, Inc.TVTX 273,420, disposed Open Form 4 filing 0001283303-26-000001
2025-09-22 S, Open-market sale Travere Therapeutics, Inc.TVTX 250,000, disposed Open Form 4 filing 0001283303-25-000005
2025-05-05 S, Open-market sale Travere Therapeutics, Inc.TVTX 103,566, disposed Open Form 4 filing 0001415889-25-012054
2025-02-12 S, Open-market sale Travere Therapeutics, Inc.TVTX 188,240, disposed Open Form 4 filing 0001415889-25-003823
2025-02-03 S, Open-market sale Travere Therapeutics, Inc.TVTX 177,051, disposed Open Form 4 filing 0001415889-25-003066
2025-01-22 S, Open-market sale Travere Therapeutics, Inc.TVTX 47,424, disposed Open Form 4 filing 0001415889-25-002004
2024-09-09 S, Open-market sale Travere Therapeutics, Inc.TVTX 50,538, disposed Open Form 4 filing 0001415889-24-023095
2024-02-01 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 41,495, disposed Open Form 4 filing 0001415889-24-002283
2024-01-23 S, Open-market sale Travere Therapeutics, Inc.TVTX 18,476, disposed Open Form 4 filing 0001415889-24-001801
2023-09-05 S, Open-market sale Travere Therapeutics, Inc.TVTX 26,699, disposed Open Form 4 filing 0001209191-23-048256
2023-05-10 S, Open-market sale Travere Therapeutics, Inc.TVTX 13,687, disposed Open Form 4 filing 0001209191-23-029012
2023-02-01 S, Open-market sale Travere Therapeutics, Inc.TVTX 57,628, disposed Open Form 4 filing 0001209191-23-006436
2023-01-24 S, Open-market sale Travere Therapeutics, Inc.TVTX 44,333, disposed Open Form 4 filing 0001209191-23-005035
2022-05-12 S, Open-market sale Travere Therapeutics, Inc.TVTX 22,584, disposed Open Form 4 filing 0001209191-22-028708
2022-05-10 S, Open-market sale Travere Therapeutics, Inc.TVTX 19,359, disposed Open Form 4 filing 0001209191-22-028708
2022-01-31 S, Open-market sale Travere Therapeutics, Inc.TVTX 36,990, disposed Open Form 4 filing 0001209191-22-006369
2022-01-24 S, Open-market sale Travere Therapeutics, Inc.TVTX 56,205, disposed Open Form 4 filing 0001209191-22-005081
2022-01-11 S, Open-market sale Travere Therapeutics, Inc.TVTX 137,000, disposed Open Form 4 filing 0001209191-22-003053
2021-08-17 S, Open-market sale Travere Therapeutics, Inc.TVTX 24,086, disposed Open Form 4 filing 0001209191-21-052078
2021-05-12 S, Open-market sale Travere Therapeutics, Inc.TVTX 31,623, disposed Open Form 4 filing 0001209191-21-032316
2021-05-11 S, Open-market sale Travere Therapeutics, Inc.TVTX 31,103, disposed Open Form 4 filing 0001209191-21-032316
2021-02-08 S, Open-market sale Travere Therapeutics, Inc.TVTX 71,055, disposed Open Form 4 filing 0001209191-21-008804
2021-02-05 S, Open-market sale Travere Therapeutics, Inc.TVTX 70,673, disposed Open Form 4 filing 0001209191-21-008804
2021-02-03 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 91,789, disposed Open Form 4 filing 0001209191-21-007633
2021-02-02 S, Open-market sale Travere Therapeutics, Inc.TVTX 2 lines 97,631, disposed Open Form 4 filing 0001209191-21-007026
2021-01-06 S, Open-market sale Travere Therapeutics, Inc.TVTX 18,583, disposed Open Form 4 filing 0001209191-21-002595
2021-01-05 S, Open-market sale Travere Therapeutics, Inc.TVTX 18,335, disposed Open Form 4 filing 0001209191-21-002595
2020-11-16 S, Open-market sale Travere Therapeutics, Inc.RTRX 59,950, disposed Open Form 4 filing 0001209191-20-058944
2020-11-13 S, Open-market sale Retrophin, Inc.RTRX 59,046, disposed Open Form 4 filing 0001209191-20-058419
2020-09-23 S, Open-market sale Retrophin, Inc.RTRX 27,720, disposed Open Form 4 filing 0001209191-20-051735
2020-09-22 S, Open-market sale Retrophin, Inc.RTRX 27,885, disposed Open Form 4 filing 0001209191-20-051613
2020-05-12 S, Open-market sale Retrophin, Inc.RTRX 2 lines 17,960, disposed Open Form 4 filing 0001209191-20-029024

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 77
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. REED ELIZABETH E, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001283303

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.